… Genital warts are a common sexually transmitted disease caused by human papillomavirus.
Imiquimod is a novel immune-response modifier … treatment of external genital warts. Methods…

… Regression of genital warts is thought to be due to an immune response (17). … an
immune-response modifier, had clinically significant efficacy in the treatment of genital warts. …

… for external genital and perianal warts is the immune response modifier, imiquimod 5% … ,
the immune response modifiers, which stimulates innate and cell mediated immune pathways …

… Treatment with imiquimod, an immune response modifier… immune response. Imiquimod
administration was also associated with a significant decrease in viral load as measured by HPV …

Imiquimod (IQ) has been successfully used in treatment of genital warts. In clinical settings,
patients responded well but wart reduction rates varied. Our aim was to find a correlation …

… , an immune-response modifler, induces local cytolcine production and reduces HPV load in
patients with external genital warts. … The genital wart studies described in the present paper …

… large wart, which may have been here unchanged or growing for months. The immune system
has … How can we bring this knowledge to help our patients with genital warts? If we could …

… HPV 11–13 but has not gained popularity in clinical practice. More recently, imiquimod was
launched as an immune-response modifier inducing anogenital wart … mediated immunity in …

… of America as an immune response modifier for the treatment of exiernal genital warls.- The
… Human papUlomavirus infection and genital warts: Update on epidemiology and treatment (…

… immune system or improving the delivery of therapeutic compounds to the affected site.
Imiquimod, a novel immune-response modifier… of patients with external genital warts. Perhaps the …